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Integrin activation
Mark H. Ginsberg*
Department of Medicine, University of California, San Diego, La Jolla, California 92093, USA
Integrin-mediated cell adhesion is important for development, 
immune responses, hemostasis and wound healing. Integrins 
also function as signal transducing receptors that can control 
intracellular pathways that regulate cell survival, proliferation, 
and cell fate. Conversely, cells can modulate the affinity of in-
tegrins for their ligands a process operationally defined as in-
tegrin activation. Analysis of activation of integrins has now 
provided a detailed molecular understanding of this unique 
form of “inside-out” signal transduction and revealed new 
paradigms of how transmembrane domains (TMD) can trans-
mit long range allosteric changes in transmembrane proteins. 
Here, we will review how talin and mediates integrin activa-
tion and how the integrin TMD can transmit these inside out 
signals. [BMB Reports 2014; 47(12): 655-659]
INTRODUCTION
Integrins, heterodimeric type I transmembrane proteins con-
sisting of α and β subunits, are a major class of receptors in-
volved in adhesive events that control development and lead 
to pathologies such as cancer and thrombosis. Eighteeen in-
tegrin α subunits and 8 β subunits heterodimerize to form 24 
different integrins (1). Each subunit contains a single trans-
membrane domain (TMD) and a short cytoplasmic tail. Besides 
mediating cell adhesion, integrins transmit signals across the 
plasma membrane that regulate cell migration, cell survival 
and growth (2). Conversely, signals from inside cells can in-
crease the binding of integrin extracellular domains to ligands, 
a process operationally defined as integrin activation. Integrin 
activation encompasses both changes in affinity of individual 
integrins due to conformational changes and avidity increases 
due to integrin clustering (3-5). Precise regulation of integrin 
activation is particularly important in controlling platelet ag-
gregation through integrin αIIbβ3 (6). Rapid activation of this 
integrin at the site of a wound is required for hemostasis (7); 
conversely inappropriate activation of αIIbβ3 can cause a pla-
telet thrombus to occlude a blood vessel resulting in my-
ocardial infarction or stroke. Here we will discuss recent prog-
ress in understanding how integrins are activated. 
INTEGRIN TMD-THE CONDUIT FOR ALLOSTERIC 
REARRANGEMENTS
Changes in the conformation of integrin extracellular domains 
are responsible for the changes in integrin monomer affinity. 
These conformational changes have been the subject of sev-
eral excellent reviews (3, 8-12) and will not be discussed here. 
Similarly, clustering of integrins can enchance the binding of 
multivalent ligands and kindlins have recently emerged as ma-
jor players in clustering (13). The capacity of intracellular sig-
nals to change the conformation of the extracellular domain 
requires a remarkable transmemebrane allosteric change, a 
change that must traverse the integrin TMD. Truncation of the 
integrins at the C-termini of extracellular domains results in 
constitutively active integrins (14), indicating that TMDs and 
cytoplasmic tails limit the activation state of integrins. Further-
more, many activating mutations, map to the α or β TMD 
(15-18). Heterodimeric interactions between α and β TMDs 
and cytoplasmic tails have been observed by co-immunopre-
cipitation (19), cysteine crosslinking (20, 21) and by NMR (22) 
in phospholipid bicelles, but not in detergent micelles (23). 
Importantly, mutations in TMDs that activate integrins in-
variably inhibit α and β TMD interactions (19). Thus, physio-
logical integrin activation is likely to require that intracellular 
signals disrupt integrin αβ TMD interactions.
　The structure of the αIIbβ3 TMD complex in a phospholipid 
bicelle (22) revealed the basis of association of the α and β 
through two interaction interfaces. The αIIb TMD helix is 
short, straight and broken at Gly991, the first residue of the 
highly-conserved Gly-Phe-Phe-Lys-Arg (GFFKR) motif in the 
membrane proximal region of the α subunits. The two Phe res-
idues of the αIIb GFFKR motif do not form a continuous helix 
but instead make a sharp turn toward β3 (Fig. 1). In this way, 
the hydrophobic side chains of those residues reside in the hy-
drophobic core of the lipid bilayer and stack against hydro-
phobic residues in the β3 TMD, particularly Trp715 and Ile719. 
The turning of the membrane-proximal region of αIIb also per-
mits the long-predicted (24) electrostatic interaction between 
αIIb Arg995 and β3 Asp723 by placing those residues in prox-
imity (Fig. 1). The structure at the inner membrane interface is 
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Fig. 1. Structure of integrin αIIbβ3 
TMD (ribbon view; αIIb in red and β3
in blue. From PDB 2K9J) showing the 
two interaction interfaces. Right, outer 
membrane clasp (OMC) illustrating the 
helical packing involving αIIb Gly 702
and 706. Left, inner membrane clasp 
(IMC) showing the electrostatic inter-
action between αIIb Arg995 and β3 
Asp723. Also depicted are the hydro-
phobic interactions of αIIb Phe992,933
with the β3 TMD. Adapted from ref-
erence (22).
unique to and likely conserved in integrins and is termed the in-
ner membrane clasp (IMC) (22). The second interface involves 
helical packing centered on β3 Gly708 and αIIb G972XXXG976 
motif at the outer membrane region and is termed the outer 
membrane clasp (OMC) (Fig. 1). Integrin β3 TMD makes a 
long and continuous helix with a 25o tilting angle to enable 
the multipoint interactions with αIIb and accommodate the ex-
tra hydrophobic residues in the β3 TMD. 
　As noted above, an important feature of the structure of the 
αIIbβ3 TMD dimer is that the helical β TMD must be precisely 
tilted to maintain simultaneous formation of the OMC and 
IMC. Precise tilt is maintained via β3 Lys716 whose alpha car-
bon resides in the hydrophobic region of the lipid bilayer but 
its positively charged ε-NH3+ is predicted to snorkel into the 
negatively charged phosphate head group region (25). Muta-
tion of Lys716 any residue other than Arg (which also contains a 
snorkeling basic side chain) reduces α-β TMD interactions and 
dramatically increases integrin activation (25). The effects of 
Lys716 mutation can be ameliorated by breaking the conti-
nuous β TMD helix into two halves by introduction of a Pro 
mutation (A711P). The Pro mutation, introduces a flexible 
hinge that partially decouples the tilting angles of inner and 
outer helices favoring simultaneous formation of OMC and 
IMC (25).
TALIN “TILTS” THE INTEGRIN β TMD TO INDUCE 
ACTIVATION
Talin regulates integrin affinity and provides a mechanical link 
between integrins and the actin cytoskeleton. Talin comprises 
a 50-kDa N-terminal FERM domain (talin head domain or 
THD) that contains a high-affinity binding site for integrin β 
tails and a 220-kDa rod domain that contains multiple binding 
sites for actin and vinculin (26). The THD is further divided in-
to F0, F1, F2 and F3 subdomains (26, 27). The F3 subdomain, 
contains the major integrin integrin β tail binding site (28, 29). 
The essential role of talin in regulating integrin affinity has 
been well documented in model cells (29-32), transgenic mice 
(33-36) and reconstituted systems with purified proteins (37). 
In in vitro systems, recombinant THD alone is sufficient to ac-
tivate αIIbβ3 reconstituted in either liposomes or phospholipid 
nanodiscs, and activation is associated with a shift towards an 
αIIbβ3 extended conformation (37). 
　We now have considerable insight into how talin induces 
this allosteric rearrangement in integrins. Talin binds to two 
sites on integrin β tails: a strong binding site centered around 
the first NPxY motif that contributes most of the binding free 
energy and a weaker membrane proximal (MP) binding site 
(38). In addition, THD also binds to negatively charged phos-
pholipids via positively-charged residues (38-40). The weak in-
teraction with the MP region has two important effects: 1) it 
brings talin Lys324 close to Asp723 of the β3 tail, thus competing 
for the Arg995-Asp723 electrostatic interactions in IMC (40); 2) it 
stabilizes α-helical structure of the β MP region and to form a 
continuous helix with the β3 TMD (38, 40). As the simultaneous 
interaction with integrin β tails and phospholipids, can change 
the tilt angle of the β3 MP tail and thus of the contiguous β3 
TMD (Fig. 2) (41). Such talin-induced motion was demon-
strated by increased fluorescence of solvatochromic dyes at-
tached to the N- or C-terminii of the β3 TMD in the presence 
of THD (41) and is further supported by molecular dynamic 
simulations (42). The change in tilting angle destabilizes α-β 
TMD interactions and shifts the equilibrium towards an acti-
vated integrin conformation. In further support of this model, 
introducing a flexible proline kink in the middle of the β3 
TMD blocks THD-induced tilting of the outer membrane seg-
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Fig. 2. Talin changes the topology of 
the β3 TMD. A peptide containing the
β3 TMD and cytoplasmic domain was 
labeled with environment sensitive bi-
manes at the outer edge of the TMD 
(N terminal labeling, Leu694) or at the
TMD cytosol interface (C-terminal la-
beling, Ile721). The peptides were indi-
vidually embedded in phospholipid na-
nodiscs and increasing concentrations 
of talin head domain (THD) were add-
ed and bimanes emission spectra were
recorded. The increased fluorescence 
indicates that both sides of the β3 TMD
were in a less polar environment sug-
gesting that THD increased the tilting 
of the β3 TMD. Adapted from refer-
ence (41).
Fig. 3. A proline kink prevents transmission of altered tilt across the β3 TMD. In the left two panels The experimental design was identi-
cal to that in Fig. 2 and depicts the talin-induced increased embedding at both the inner (where THD binds) and outer edges of the 
TMD. Introduction of a flexible kink by β3 (A711P) mutation (right two panels) prevents the transmission of increased embedding of the 
inner TMD to the outer region. Adapted from reference (41). 
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ment without blocking tilting of the inner membrane segment 
(Fig. 3). Integrins bearing this mutation are remarkably resistant 
to talin induced integrin activation (41).
SUMMARY AND CONCLUSIONS
　Integrin activation was first observed in 1978 in integrin 
αIIbβ3 and it has proved to be a conserved property of β1, β2, 
and β3 integrins. As summarized here, our understanding of 
this unique form of transmembrane signal transduction has 
moved from a black box in which agonists, such as thrombin, 
caused a change in the affinity of integrin αIIbβ3. Today, cell 
biological and reverse genetic experiments have verified that 
talin binding to the integrin β cytoplasmic domain is a final 
common step in activation. Structural studies have revealed 
how two binding interfaces of talin with the integrin in combi-
nation with talin membrane binding sites can effect this form 
of transmembrane allostery. Studies have also revealed unique 
features of the heterodimeric integrin TMD that form a stable 
yet dynamic αβ TMD interaction that enables transmission of 
the activation signal across the phospholipid bilayer. The les-
sons learned in studying integrin transmembrane signaling, 
such as the importance of snorkeling basic residues in main-
taining TMD topology, are likely to pertain to other examples 
of transmembrane signaling through transmembrane receptors. 
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